Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Epoprostenol sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for epoprostenol sodium and what is the scope of epoprostenol sodium freedom to operate?

Epoprostenol sodium
is the generic ingredient in three branded drugs marketed by Glaxosmithkline Llc, Actelion Pharms Ltd, and Teva Pharms Usa, and is included in three NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Epoprostenol sodium has fourteen patent family members in thirteen countries.

There are seven drug master file entries for epoprostenol sodium. Three suppliers are listed for this compound.

Summary for Generic Name: epoprostenol sodium

Drug Master File Entries: see list7
Suppliers / Packagers: see list3
Bulk Api Vendors: see list19
Clinical Trials: see list929
Patent Applications: see list6,386
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:epoprostenol sodium at DailyMed

Pharmacology for Ingredient: epoprostenol sodium

Ingredient-typeProstaglandins I
Drug ClassProstacycline Vasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actelion Pharms Ltd
epoprostenol sodium
INJECTABLE;INJECTION022260-002Jun 28, 2012RXYesNo8,598,227► Subscribe ► Subscribe
Glaxosmithkline Llc
epoprostenol sodium
INJECTABLE;INJECTION020444-001Sep 20, 1995APRXYesYes► Subscribe► Subscribe
Teva Pharms Usa
epoprostenol sodium
INJECTABLE;INJECTION078396-002Apr 23, 2008APRXNoNo► Subscribe► Subscribe
Actelion Pharms Ltd
epoprostenol sodium
INJECTABLE;INJECTION022260-001Jun 27, 2008RXYesYes8,318,802► SubscribeY ► Subscribe
Actelion Pharms Ltd
epoprostenol sodium
INJECTABLE;INJECTION022260-002Jun 28, 2012RXYesNo8,318,802► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus